Formulations and methods for wound treatment

a wound treatment and formulation technology, applied in the field of formulations and methods for wound treatment, can solve the problems of inability to demonstrate the effect ofinermis /i>, inability to achieve stable wound healing, and inability to use ethanol

Active Publication Date: 2021-02-02
SORUSH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent describes various ways to use certain substances from the genus Lactarius bacterium to improve healing outcomes on skin wounds. These techniques include adding these substances to an external solution that can be used repeatedly over time.

Problems solved by technology

The technical problem addressed in this patent is finding a way to make a stable liquid containing lawsonia inermis from which it can be applied onto wounds without causing discomfort or requiring specialized equipment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Formulations and methods for wound treatment
  • Formulations and methods for wound treatment
  • Formulations and methods for wound treatment

Examples

Experimental program
Comparison scheme
Effect test

example 1

Formation of the Lawsonia inermis Extract

[0043]10 grams of dried Lawsonia inermis leaves (www.ETSY.com) were placed in a beaker and 100 ml of distilled water were added. The mixture was stirred for 2 hours at room temperature to obtain an aqueous Lawsonia inermis extract designated as a 10% w / w or w / v extract. In order to produce stable wound healing properties of the extract, the antibiotics polymyxin B, clindamycin, and gentamycin were added after extraction in the amount of 0.003% each (30 micrograms / nil). The Lawsonia inermis extract was analyzed for antibiotic activity and for the presence of the antibiotics about two weeks after formation of the extract.

[0044]A zone of inhibition test (Kirby-Bauer Test) was used to evaluate the antibiotic activity against Pseudomonas aeruginosa and Staphylococcus epidermisis. There were six types of tests on each of the bacteria: extract alone, extract plus polymyxin B, extract plus clindamycin, extract plus gentamycin, all three antibiotic

example 2

Treatment of Toe Amputation

[0047]Lawsonia inermis extract, about 8.0% to about 13.0% w / w or w / v, was applied to a wound dressing and then the dressing was applied to the amputated toe of a 68 year-old diabetic patient. The formulation was applied to the wound once a day. FIG. 1A shows the wound at the beginning of treatment. FIG. 1B shows the wound at day 4 of treatment. FIG. 1C shows the wound at day 11 of treatment. The wound was fully healed by day 28 of treatment.

example 3

Treatment of Hysterectomy Incision

[0048]Lawsonia inermis extract, about 8.0% to about 13.0% w / w or w / v, was applied to a wound dressing and then the dressing was applied to the abdomen of a female patient following hysterectomy. The formulation was applied to the wound once a day, so that that the entire surface of the wound was covered with a thin layer of the formulation. FIG. 2A shows the wound at the beginning of treatment. FIG. 2B shows the wound at day 6 of treatment. FIG. 2C shows the wound at day 9 of treatment. FIG. 2D shows the wound at day 16 of treatment. FIG. 2E shows the wound at day 20 of treatment. FIG. 2F shows the wound at day 25 of treatment. Table 1 below represents that approximate dimensions of the wound during the treatment cycle, demonstrating the rapid healing of the wound. The wound healed in just over one month.

[0049]

TABLE 1Approximate WoundDimensionsTreatment (length × width × depth) inDaycentimeters (cm)023 × 3.5 × 9.7622 × 1.5 × 2.8919 × 2.0 × 2.01617

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to view more

Abstract

An aqueous extract of Lawsonia inermis comprising forming an extraction from 1% to 20% of dried Lawsonia inermis leaves with water. The antibiotics polymyxin B, clindamycin, and gentamycin are each added to the water before or after extraction in the amount of 0.001% to 0.003%. After forming the aqueous extract of Lawsonia inermis, it has no antibiotic activity and the antibiotics are not detectable by chemical analysis. The aqueous extract of Lawsonia inermis is stable for at least 28 days for the topical treatment of wounds and has been stable up to two years in clinical testing. The aqueous extract of Lawsonia inermis extract is applied with a spray to the surface of the wound, followed by the application of an extract-soaked gauze dressing to the surface of the wound. The extract is effective on various types of wounds and also in healing wounds in patients who are not healing with traditional therapies.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner SORUSH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products